WEST PHARM.SVCS DL-,25/ US9553061055 /
2024-11-18 5:32:08 PM | Chg. - | Volume | Bid11:43:17 AM | Ask11:43:17 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
290.90EUR | - | 88 Turnover: 25,869 |
286.60Bid Size: 18 | 291.50Ask Size: 18 | 21 bill.EUR | - | - |
Assets
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 822 | 839.3000 | 943.2000 | 1,057.5000 | 1,158.3000 | ||||||
Intangible Assets | 20.3000 | 29.8000 | 30.5000 | 23 | 18.4000 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | 1,084.5000 | 1,282.7000 | 1,420.1000 | 1,571.8000 | 1,697.3000 | ||||||
Inventories | 214.5000 | 235.7000 | 321.3000 | 378.4000 | 414.8000 | ||||||
Accounts Receivable | 288.2000 | 319.3000 | 385.3000 | 489 | 507.4000 | ||||||
Cash and Cash Equivalents | 337.4000 | 439.1000 | 615.5000 | 762.6000 | 894.3000 | ||||||
Current Assets | 894.4000 | 1,058.7000 | 1,373.7000 | 1,742 | 1,919.5000 | ||||||
Total Assets | 1,978.9000 | 2,341.4000 | 2,793.8000 | 3,313.8000 | 3,616.8000 |
Liabilities
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 130.4000 | 156.8000 | 213.1000 | 232.2000 | 215.4000 | ||||||
Long-term debt | 196 | 255 | 252.9000 | 208.8000 | 206.7000 | ||||||
Liabilities to Banks | .1000 | 2.3000 | - | - | - | ||||||
Provisions | 22.9000 | 21.9000 | - | - | - | ||||||
Liabilities | 582.6000 | 768.2000 | 939.3000 | 978.4000 | 931.9000 | ||||||
Share Capital | 18.8000 | 18.8000 | 18.8000 | 18.8000 | 18.8000 | ||||||
Total Equity | 1,396.3000 | 1,573.2000 | 1,854.5000 | 2,335.4000 | 2,684.9000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 1,978.9000 | 2,341.4000 | 2,793.8000 | 3,313.8000 | 3,616.8000 |
Income Statement
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,717.4000 | 1,839.9000 | 2,146.9000 | 2,831.6000 | 2,886.9000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 240.3000 | 296.6000 | 406.9000 | 752.3000 | 734 | ||||||
Interest Income | 8.4000 | 8.5000 | 8.2000 | 8.2000 | 7.9000 | ||||||
Income Before Taxes | 240.7000 | 291.8000 | 401.3000 | 748.9000 | 679.9000 | ||||||
Income Taxes | 41.4000 | 59 | 72.5000 | 107.2000 | 114.7000 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 206.9000 | 241.7000 | 346.2000 | 661.8000 | 585.9000 |
Per Share
Cash Flow
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 288.6000 | 367.2000 | 472.5000 | 584 | 724 | ||||||
Cash Flow from Investing Activities | -100.8000 | -228 | -179.5000 | -253.1000 | -288.2000 | ||||||
Cash Flow from Financing | -80.7000 | -36.8000 | -137.1000 | -168.1000 | -293.6000 | ||||||
Decrease / Increase in Cash | 101.5000 | 101.7000 | 176.4000 | 147.1000 | 131.7000 | ||||||
Employees | 7,700 | 8,200 | - | - | - |